Angela Garinis, Ph.D. - National Center for Rehabilitative Auditory Research (NCRAR)
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

National Center for Rehabilitative Auditory Research (NCRAR)

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Angela Garinis, Ph.D.

Email: garinis@ohsu.edu  
Telephone: 503-220-8262 x54692

Current Appointments

  • Research Investigator, NCRAR
  • Assistant Professor, Oregon Hearing Research Center at Oregon Health & Science University

Research Interests

  • Improving early detection methods for ototoxicity
  • Combining behavioral and physiologic tests methods to investigate auditory function
  • Examining the effects of aminoglycoside-induced ototoxicity in patients with cystic fibrosis and infants in the neonatal intensive care units
  • Auditory development 

Current Research Project(s)

Effects of Intravenous Aminoglycoside Treatments on the Cochlear and Medial Efferent Auditory System in Patients with Cystic Fibrosis
Principal Investigator: Angela Garinis, PhD

Selected Recent Publications

Steyger, PS, Garinis, AC. (2019) Genetic Contributions to Age-Related Hearing Loss. Hearing Journal: 72 (5) 10-13.

Garinis, A.C., Keefe, D.H., Hunter, L.L. Fitzpatrick, D., McMillan, G.P. Putterman, D.B., Gold, J. Feeney, M. P. (2018) Chirp-Evoked Otoacoustic Emissions and Middle Ear Absorbance for Monitoring Ototoxicity in Cystic Fibrosis Patients. Ear Hear, 39(1):69-84. PMID: 28708814.

Putterman, D.B., Keefe, D.H., Hunter, L.L. Garinis, A.C., Fitzpatrick, D., McMillan, G.P. Feeney, M. P. (2018) Assessing Sensorineural Hearing Loss using Various Transient Evoked-Otoacoustic Emission Stimulus Conditions. Ear Hear, 38(4): 507-520. PMID: 28437273.

Garinis A.C., Liao S., Cross C.P., Galati J., Middaugh J.L., Mace J.C., Wood A.M., McEvoy L., Moneta L., Lubianski T., Coopersmith N., Vigo N., Hart C., Riddle A., Ettinger O., Nold C., Durham H, MacArthur C, McEvoy C, Steyger PS. (2017) Effect of gentamicin and levels of ambient sound on hearing screening outcomes in the neonatal intensive care unit: A pilot study. Int J Pediatr Otorhinolaryngol, 97: 42-50. PMID: 28483249.

Garinis, A.C., Cornell, A., Allada, G., Fennelly, K.P., Maggiore, R.J., Konrad-Martin, D. (2017) Ototoxicity monitoring through the eyes of the treating physician: Perspectives from pulmonology and medical oncology. Int J Audiol, (5): 1-6. PMID: 28978238.

Garinis, A.C., Cross, C., Srikanth, P., Carroll, K., Feeney, M.P., Keefe, D.H., Hunter, L.L., Putterman, D.B., Cohen, D., Gold, J., Steyger, P. S. (2017) The Cumulative Effects of Intravenous Antibiotic Treatments on Hearing in Patients with Cystic Fibrosis. J Cyst Fibros, 16(3): 401-409. PMID: 28238634.

Garinis, A.C., Kemph, A., Tharpe, A.M., Weitkamp, J. H., McEvoy, C. Steyger, P.S. (2017) Monitoring neonates for ototoxicity. Int J Audiol, June 22: 1-8 [Epub ahead of print]. PMID: 28949262.

Konrad-Martin D., Poling G.L., Garinis A.C., Ortiz C.E., Hopper J., O'Connell Bennett K., Dille M.F. (2017) Applying U.S. national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions. Int J Audiol, Nov 20: 1-16. [Epub ahead of print]  PMID: 29157038.

Feeney, M.P., Keefe, D.K., Hunter, L., Fitzpatrick, D., Garinis, A.G., Putterman, D., McMillan, G., (2017). Normative wideband reflectance, equivalent admittance at the tympanic membrane and acoustic stapedius reflex threshold in adults. Ear Hear, 38(3): e142-e160. PMID: 28045835.

Cross, C.P., Liao S., Urdang, Z.D., Garinis, A. Steyger, P. (2015) Effect of sepsis and systemic inflammatory response syndrome on neonatal hearing screening outcomes following gentamycin exposure. Int J Pediatr Otorhinolaryngol, 79(11): 1915-9. PMID: 26384832.

Feeney, M.P., Stover, B., Keefe, D.H., Garinis, A.C., Day, J.E. & Seixas, N. (2014) Sources of variability in wideband energy reflectance measurements in adults. J Acad Aud, 25(5): 449-461. PMID: 25257719.

Abdala, C., Mishra, S., & Garinis, A. (2013) Maturation of the human medial efferent reflex revisited. J Acoust Soc Am, 133(2): 938-50. PMID: 23363111, PMCID: PMC3574130.  

Garinis, A., Glattke, T., & Cone, B. (2011) The MOC reflex during active listening to speech, J Speech Lang Hear Res, 54(5): 1464-76.

Garinis, A.C., Werner, L. & Abdala, C. (2011) The relationship between MOC reflex and masked threshold. J Acoust Soc Am, 282(1-2): 128-37. PMID: 21878379, PMCID: PMC3242450. 

Cone-Wesson, B. & Garinis, A. (2009) Auditory steady state responses and speech feature discrimination in infants, J Am Acad Audiol, 20(10):629-643.

Garinis, A.C., Glattke, T. & Cone-Wesson, B.K. (2008) TEOAE suppression in adults with learning disabilities. Int J Audiol, 47(10): 607-614.   PMID: 18923982.

Garinis, A.C. & Cone-Wesson, B.K. (2007) Effects of stimulus level on CAEP evoked by speech. J Am Acad Audiol, 18(2): 107-116. PMID: 17402297.

Selected Recent Presentations


North American Cystic Fibrosis Conference, Denver, CO-poster presentations (2018):
1) Effects of Intravenous Aminoglycoside Treatments on the Efferent Auditory System in Cystic Fibrosis Patients
2) Aminoglycoside Pharmacokinetic Exposure Related to Hearing Loss in Children with Cystic Fibrosis

North American Cystic Fibrosis Conference, Orlando, FL-poster presentation (2016)
Quantifying the effects of medication dosage and age on hearing in cystic fibrosis patients receiving obligate intravenous antibiotic treatments

Association for Research in Otolaryngology (ARO), Phoenix, AZ-poster presentation (2016)
Quantifying the effects of medication dosage and age on hearing in cystic fibrosis patients receiving obligate intravenous antibiotic treatments

American Auditory Society (AAS), Scottsdale-poster presentation (2016)
Distortion-product otoacoustic emissions for monitoring ototoxicity in cystic fibrosis patients